MANFREDINI, Rossella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.620
EU - Europa 7.331
AS - Asia 6.285
SA - Sud America 886
AF - Africa 110
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 18
Totale 30.282
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.430
GB - Regno Unito 2.503
CN - Cina 1.860
SG - Singapore 1.773
IT - Italia 1.511
HK - Hong Kong 1.198
SE - Svezia 937
BR - Brasile 731
DE - Germania 573
RU - Federazione Russa 404
VN - Vietnam 366
FR - Francia 267
FI - Finlandia 266
KR - Corea 254
UA - Ucraina 253
TR - Turchia 234
ID - Indonesia 132
CA - Canada 130
IN - India 128
BG - Bulgaria 118
NL - Olanda 74
SI - Slovenia 65
PL - Polonia 58
JP - Giappone 57
AR - Argentina 56
BE - Belgio 52
BD - Bangladesh 45
ZA - Sudafrica 44
IE - Irlanda 40
MX - Messico 40
IR - Iran 38
LT - Lituania 38
ES - Italia 33
IQ - Iraq 32
EC - Ecuador 31
CZ - Repubblica Ceca 29
AU - Australia 28
PK - Pakistan 25
AT - Austria 21
CO - Colombia 21
TW - Taiwan 18
CH - Svizzera 16
CL - Cile 15
MA - Marocco 15
MY - Malesia 15
KE - Kenya 14
AE - Emirati Arabi Uniti 13
EU - Europa 13
IL - Israele 13
UZ - Uzbekistan 13
EG - Egitto 12
QA - Qatar 12
PT - Portogallo 11
PY - Paraguay 9
SA - Arabia Saudita 9
VE - Venezuela 9
NP - Nepal 7
PE - Perù 7
PH - Filippine 7
RO - Romania 7
TN - Tunisia 7
AL - Albania 6
DK - Danimarca 6
DZ - Algeria 6
LU - Lussemburgo 6
NO - Norvegia 6
GR - Grecia 5
HU - Ungheria 5
JM - Giamaica 5
AM - Armenia 4
DO - Repubblica Dominicana 4
GE - Georgia 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AZ - Azerbaigian 3
BH - Bahrain 3
BO - Bolivia 3
HR - Croazia 3
KG - Kirghizistan 3
KW - Kuwait 3
KZ - Kazakistan 3
MD - Moldavia 3
NZ - Nuova Zelanda 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
BA - Bosnia-Erzegovina 2
BW - Botswana 2
BZ - Belize 2
CR - Costa Rica 2
EE - Estonia 2
IM - Isola di Man 2
IS - Islanda 2
OM - Oman 2
PS - Palestinian Territory 2
SN - Senegal 2
XK - ???statistics.table.value.countryCode.XK??? 2
BB - Barbados 1
BJ - Benin 1
BY - Bielorussia 1
Totale 30.262
Salva come PNG Salva come JPEG
Città #
Southend 1.849
Fairfield 1.588
Santa Clara 1.481
Ashburn 1.446
Hong Kong 1.180
Singapore 1.061
Chandler 1.015
Woodbridge 978
Houston 732
Seattle 616
Ann Arbor 554
Wilmington 539
Cambridge 528
Nyköping 514
Hefei 501
Jacksonville 433
Dearborn 399
Chicago 373
London 367
Beijing 362
Los Angeles 322
Modena 301
Seoul 238
Salt Lake City 178
San Diego 164
New York 162
Helsinki 136
Munich 128
Izmir 125
Princeton 123
Sofia 117
Ho Chi Minh City 110
Jakarta 107
Shanghai 101
Milan 96
Buffalo 94
The Dalles 91
Council Bluffs 90
Bologna 89
Eugene 86
Tampa 85
Moscow 83
Fremont 72
São Paulo 67
Hanoi 65
Elk Grove Village 64
Des Moines 63
Dallas 56
Bremen 53
Reggio Emilia 52
Turku 52
Brussels 46
Redwood City 44
Falls Church 43
Rome 43
Frankfurt am Main 41
Montreal 41
Shenzhen 41
Miami 39
Phoenix 38
Tokyo 38
Lancaster 37
Dublin 36
Sterling 36
Nuremberg 35
Warsaw 33
Toronto 32
Columbus 31
Dong Ket 31
Boardman 30
Denver 29
Ottawa 29
Falkenstein 28
Hillsboro 28
Parma 27
Sant'Ilario d'Enza 25
Atlanta 24
Johannesburg 24
Brooklyn 23
Florence 23
Orem 23
Guangzhou 22
Rio de Janeiro 22
Kent 21
Palermo 21
Belo Horizonte 20
Chennai 20
Paris 20
Poplar 20
Redondo Beach 20
Brasília 19
Brno 19
Detroit 19
Manchester 18
Stockholm 18
Monmouth Junction 17
San Mateo 17
Verona 17
Hounslow 16
Kraków 16
Totale 21.446
Salva come PNG Salva come JPEG
Nome #
Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms 495
c-Myb supports erythropoiesis through the transactivation of KLF1 and LMO2 expression. 451
Implementation of an NGS-based workflow for BRCA1 and BRCA2 mutation screening 399
c-Myb supports erythropoiesis by transactivating KLF1 and LMO2 expression 391
Virally mediated MafB transduction induces the monocyte commitment of human CD34+ hematopoietic stem/progenitor cells 387
Bone marrow-derived hematopoietic cells undergo myogenic differentiation following a Pax-7 independent pathway 374
C-Myb Restrains Megakaryopoiesis through the Hsa-MiR-486-3p-Driven Down-Regulation of C-Maf 373
Deregulated expression of miR-29a-3p, miR-494-3p and miR-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cells 371
Purinergic signaling inhibits human acute myeloblastic leukemia cell proliferation, migration, and engraftment in immunodeficient mice 370
Involvement of MAF/SPP1 axis in the development of bone marrow fibrosis in PMF patients 370
The extracellular nucleotide UTP is a potent inducer of hematopoietic stem cell migration 352
miR-382-5p Controls Hematopoietic Stem Cell Differentiation Through the Downregulation of MXD1 349
Correlation between differentiation plasticity and mRNA expression profiling of CD34+-derived CD14- and CD14+ human normal myeloid precursors 349
MicroRNA expression profile in granulocytes from primary myelofibrosis patients 344
Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms' tumor gene 1 (WT1) 343
Unravelling the Complexity of Inherited Retinal Dystrophies Molecular Testing: Added Value of Targeted Next-Generation Sequencing 335
Mutations and prognosis in primary myelofibrosis 332
Co-culture of hematopoietic stem/progenitor cells with human osteblasts favours mono/macrophage differentiation at the expense of the erythroid lineage 330
Eosinophils, but not neutrophils, exibit an efficient DNA repair machinary and high nucleolar activity 329
The kinetic status of hematopoietic stem cell subpopulations underlies a differential expression of genes involved in self-renewal, commitment, and engraftment. 326
miR-494-3p overexpression promotes megakaryocytopoiesis in primary myelofibrosis hematopoietic stem/progenitor cells by targeting SOCS6 325
Molecular profile of CD34+ stem/progenitor cells according to JAK2V617F mutation status in essential thrombocythemia. 322
Transcriptional profiles in melanocytes from clinically unaffected skin distinguish the neoplastic growth pattern in patients with melanoma 321
Calreticulin Ins5 and Del52 mutations impair unfolded protein and oxidative stress responses in K562 cells expressing CALR mutants 316
miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells: role of miR-155/JARID2 axis in abnormal megakaryopoiesis 315
Integrative Analysis Of mRNA/miRNA Expression Profiles Identified JARID2 As a Shared Target Of Deregulated Mirnas In Primary Myelofibrosis 310
Genomic landscape of megakaryopoiesis and platelet function defects 305
Identification of a molecular signature predictive of sensitivity to differentiation induction in acute myeloid leukemia 305
Calreticulin affects hematopoietic stem/progenitor cell fate by impacting erythroid and megakaryocytic differentiation 304
Amplicon-based Next Generation Sequencing: an effective approach to molecular diagnosis of Epidermolysis Bullosa 304
Analytic and Dynamic Secretory Profile of Patient-Derived Cytokine-Induced Killer Cells 303
Purinergic stimulation of human mesenchymal stem cells potentiates their chemotactic response to CXCL12 and increases the homing capacity and production of proinflammatory cytokines 302
Amplicon-based next-generation sequencing: an effective approach for the molecular diagnosis of epidermolysis bullosa 301
CALR mutational status identifies different disease subtypes of essential thrombocythemia showing distinct expression profiles 300
Epidemiology and clinical relevance of mutations in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 359 patients of the AGIMM group 300
Antisense inhibition of c-fes proto-oncogene blocks PMA-induced macrophage differentiation in HL60 and in FDC-P1/MAC-11 cells 299
Abnormal expression patterns of WT1-as, MEG3 and ANRIL long non-coding RNAs in CD34+ cells from patients with primary myelofibrosis and their clinical correlations 298
Preclinical study for treatment of hypospadias by advanced therapy medicinal products 298
Role of miR-34a-5p in Hematopoietic Progenitor Cells Proliferation and Fate Decision: Novel Insights into the Pathogenesis of Primary Myelofibrosis 295
Role of TGF-β1/miR-382-5p/SOD2 axis in the induction of oxidative stress in CD34+ cells from primary myelofibrosis 292
Requirement of the coiled-coil domains of p92(c-Fes) for nuclear localization in myeloid cells upon induction of differentiation 285
Gene expression profile of vitamin D3 treated HL60 cells shows an incomplete molecular phenotypic conversion to monocytes 281
A data-driven network model of primary myelofibrosis: transcriptional and post-transcriptional alterations in CD34+ cells 275
Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study 274
Valproic acid triggers erythro/megakaryocyte lineage decision through induction of GFI1B and MLLT3 expression 271
Monocyte Distribution Width (MDW) as novel inflammatory marker with prognostic significance in COVID-19 patients 269
Isolation of human keratinocyte stem cells and high-throughput screening approach for their characterization 258
A functionally active RAR alpha nuclear receptor is expressed in retinoic acid non responsive early myeloblastic cell lines 256
Impact Of Prognostically Detrimental Mutations (ASXL1, EZH2, SRSF2, IDH1/2) On Outcomes In Patients With Myelofibrosis Treated With Ruxolitinib In COMFORT-II 247
Differential proteomic profile of leukemic CD34+ progenitor cells from chronic myeloid leukemia patients 247
The isopeptidase inhibitor 2cPE triggers proteotoxic stress and ATM activation in chronic lymphocytic leukemia cells 245
Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12low/neg accessory cells with dendritic-cell features 244
Bone marrow-specific loss of ABI1 induces myeloproliferative neoplasm with features resembling, human myelofibrosis 242
Expression And Function Of Nerve Growth-Factor And Nerve Growth-Factor Receptor On Cultured Keratinocytes. 241
Antiapoptotic effect of c-fes protooncogene during granulocytic differentiation 241
Terminal differentiation 239
Molecular and functional analysis of the stem cell compartment of chronic myelogenous leukemia reveals the presence of a CD34- cell population with intrinsic resistance to imatinib 230
Development of an IL-6 antagonist peptide that induces apoptosis in IL-6 dependent 7TD1 cells. 229
Wnt/CTNNB1 signal transduction pathway inhibits the expression of ZFP36 in squamous cell carcinoma, by inducing transcriptional repressors SNAI1, SLUG and TWIST 229
Role of CD34 antigen in myeloid differentiation of human hematopoietic progenitor cells 227
Molecular and functional characterization of CD133+ stem/progenitor cells infused in patients with end-stage liver disease reveals their interplay with stromal liver cells 226
Characterisation and discovery of novel miRNAs and moRNAs in JAK2V617F mutated SET2 cells 224
Extracellular purines promote the differentiation of human bone marrow-derived mesenchymal stem cells to the osteogenic and adipogenic lineages 223
All-trans-retinoic acid induces simultaneously granulocytic differentiation and expression of inflammatory cytokines in HL-60 cells 222
Expression of B7 costimulatory molecule in cultured human epidermal Langerhans cells is regulated at the mRNA level. 221
ANTISENSE STRATEGIES TO CHARACTERIZE THE ROLE OF GENES AND ONCOGENES INVOLVED IN MYELOID DIFFERENTIATION 217
Presence of a functional vitamin D receptor does not correlate with vitamin D3 phenotypic effects in myeloid differentiation 217
Mutated clones driving leukemic transformation are already detectable at the single-cell level in CD34-positive cells in the chronic phase of primary myelofibrosis 213
BTK Inhibitors Impair Platelet-Mediated Antifungal Activity 213
IDENTIFICATION OF A MOLECULAR SIGNATURE PREDICTIVE OF REFRACTORINESS IN ACUTE MYELOID LEUKEMIA 211
IDENTIFICATION OF A MOLECULAR SIGNATURE PREDICTIVE OF REFRACTORINESS IN ACUTE MYELOID LEUKEMIA 211
AMPLICON-BASED NGS: AN EFFECTIVE APPROACH FOR THE MOLECULAR DIAGNOSIS OF EPIDERMOLYSIS BULLOSA 210
Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis 210
Antisense strategies in leukemias 203
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 201
ROLE OF C-FES PROTOONCOGENE IN MYELOID DIFFERENTIATION 201
Genomic analysis of hematopoietic stem cell at the single-cell level: Optimization of cell fixation and whole genome amplification (WGA) protocol 201
Chromosome 9p trisomy increases stem cells clonogenic potential and fosters T-cell exhaustion in JAK2-mutant myeloproliferative neoplasms 197
Cytokine-induced killer cells express CD39, CD38, CD203a, CD73 ectoenzymes and P1 adenosinergic receptors 191
Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model 190
The Response to Oxidative Damage Correlates with Driver Mutations and Clinical Outcome in Patients with Myelofibrosis 188
The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: An international study of 797 patients 187
Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: Pathogenetic insight and diagnostic value 186
Mechanistic insight into WEB-2170-induced apoptosis in human acute myelogenous leukemia cells. the crucial role of PTEN. 185
Characterization of new ATM deletion associated with hereditary breast cancer 180
SOX2 Is a Univocal Marker for Human Oral Mucosa Epithelium Useful in Post-COMET Patient Characterization 180
Physiological levels of 1 alpha, 25 di-hydroxyvitamin D3 induce the monocytic commitment of CD34+ hematopoietic progenitors 179
Tie2 expressing monocytes in the spleen of patients with primary myelofibrosis 176
Inhibition of c-fes expression by an antisense oligomer causes apoptosis oh HL60 cells induced to granulocytic differentiation 174
Gene Expression profile of Vitamin D3 treated HL60 cells shows a phenotypic but not a complete functional conversion to monocytes 171
Automated capture-based NGS workflow: one thousand patients experience in a clinical routine framework 166
ANTISENSE STRATEGIES IN LEUKEMIA 165
Chromosome 9p Duplication Promotes T-Cell Exhaustion and Enhances Stem Cell Clonogenic Potential in JAK2-Mutant Myeloproliferative Neoplasms 164
MITOCHONDRIAL-DNA DELETION IN A PATIENT WITH PROGRESSIVE OPHTHALMOPLEGIA 163
Ivar, an interpretation‐oriented tool to manage the update and revision of variant annotation and classification 163
Prognostic Relevance of Multi-Antigenic Myeloma-Specific T-Cell Assay in Patients with Monoclonal Gammopathies 161
Distribution of different classes of CSF3R mutations and co-mutational pattern in 360 myeloid neoplasia 160
Increased Plasma Levels of lncRNAs LINC01268, GAS5 and MALAT1 Correlate with Negative Prognostic Factors in Myelofibrosis 156
Novel Molecular Insights into Leukemic Evolution of Myeloproliferative Neoplasms: A Single Cell Perspective 155
Requirement of the coiled coil domains of p92c-Fes for nuclear translocation in myeloid cells upon induction of differentiation 152
Totale 26.128
Salva come PNG Salva come JPEG
Categoria #
all - tutte 128.041
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 128.041
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.873 0 0 0 0 0 249 214 341 175 429 269 196
2021/20222.630 136 228 299 162 124 153 137 151 265 196 430 349
2022/20233.118 379 406 297 272 333 409 67 284 345 44 143 139
2023/20242.073 81 91 171 177 325 177 303 252 41 72 117 266
2024/20256.651 178 65 120 395 1.226 933 603 449 741 287 827 827
2025/20266.228 807 473 882 1.510 2.356 200 0 0 0 0 0 0
Totale 30.524